Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colonic Neoplasms 66Rectal Neoplasms 61Colorectal Neoplasms 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Neoplasm Metastasis 12Lymphoma 12Burkitt Lymphoma 11Leukemia 9Unspecified Adult Solid Tumor, Protocol Specific 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Gallbladder Neoplasms 5Bile Duct Neoplasms 5Acquired Immunodeficiency Syndrome 5Neoplasms 4HIV Infections 4Osteosarcoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Esophageal Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Neoplasms, Unknown Primary 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2

Interventions

Carboplatin 28Paclitaxel 21Cisplatin 9Topotecan 8Docetaxel 7Taxes 6Oxaliplatin 5Gemcitabine 5Chemotherapy, Adjuvant 5Bevacizumab 5aldesleukin 4Interleukin-12 Subunit p35 4Erlotinib Hydrochloride 4Drug Therapy 4Interleukin-12 3Immunohistochemistry 3Imatinib Mesylate 3Gene Expression Profiling 3Flow Cytometry 3Filgrastim 3Cyclophosphamide 3Amplified Fragment Length Polymorphism Analysis 3trioctyl phosphine oxide 2temsirolimus 2sargramostim 2oregovomab 2ixabepilone 2irofulven 2cediranib 2carboxyamido-triazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinoma, Ovarian Epithelial × Leucovorin × Clear all
NCT00004206 2014-06-24

Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡